In what is seen as a New Year’s gift of sorts to people living with HIV/AIDS, the Indian Patent office has rejected Abbott’s patent application on its heat-stable version of the Lopinavir/Ritonavir drug. The Hindu -Business Line
In what is seen as a New Year’s gift of sorts to people living with HIV/AIDS, the Indian Patent office has rejected Abbott’s patent application on its heat-stable version of the Lopinavir/Ritonavir drug. The Hindu -Business Line
Join us to stay updated
and help make lifesaving medicines accessible to all